Form 8.3 - Avadel Pharmaceuticals plc

FORM8.3IRISHTAKEOVERPANELDISCLOSUREUNDERRULE8.3OFTHEIRISHTAKEOVERPANEL ACT,1997,TAKEOVERRULES,2013DEALINGSBYPERSONSWITHINTERESTSINRELEVANTSECURITIESREPRESENTING1%ORMORE1. KEYINFORMATIONNameofpersondealing(Note1) State Street Global Advisors & Affiliates Companydealtin Avadel Pharmaceuticals plc Classofrelevantsecuritytowhich the dealingsbeingdisclosedrelate(Note...

Dublin, 25/11/2025 (informazione.news - comunicati stampa - servizi)

FORM8.3

IRISHTAKEOVERPANEL

DISCLOSUREUNDERRULE8.3OFTHEIRISHTAKEOVERPANEL ACT,1997,TAKEOVERRULES,2013

DEALINGSBYPERSONSWITHINTERESTSINRELEVANTSECURITIESREPRESENTING1%ORMORE

1. KEYINFORMATION

Nameofpersondealing(Note1)	State Street Global Advisors & Affiliates
Companydealtin	Avadel Pharmaceuticals plc
Classofrelevantsecuritytowhich the dealingsbeingdisclosedrelate(Note2)	$0.01 ordinary shares
Dateofdealing	24th November 2025

2. INTERESTSANDSHORTPOSITIONS
(110)   Interestsandshortpositions(followingdealing)intheclassofrelevantsecurity dealtin (Note 3)

	Long		Short
	Number	(%)	Number	(%)
(1)Relevantsecurities	2,274,899	2.33554%
(2)Derivatives(otherthanoptions)	N/A	N/A
(3)Optionsandagreementsto purchase/sell	N/A	N/A
Total	2,274,899	2.33554%

        

(b) Interestsandshortpositionsinrelevantsecuritiesofthecompany,other thanthe classdealtin (Note 3)        

Classofrelevantsecurity:	Long		Short
	Number	(%)	Number	(%)
(1)Relevantsecurities	N/A
(2)Derivatives(otherthanoptions)	N/A
(3)Optionsandagreementstopurchase/sell	N/A
Total	N/A

3. DEALINGS (Note 4)
(110)   Purchasesandsales

Purchase/sale	Numberofrelevantsecurities	Priceperunit (Note 5)
Purchase	3,100	22.92
Purchase	2,200	22.92
Sale	3,100	22.92
Sale	2,200	22.92

        
(b) Derivativestransactions(otherthanoptionstransactions)

Productname, e.g.CFD	Natureoftransaction (Note 6)	Numberofrelevantsecurities (Note 7)	Priceperunit (Note 5)
N/A

        
(c) Optionstransactionsinrespectofexistingrelevantsecurities

(i) Writing,selling,purchasingorvarying

Productname, e.g.calloption	Writing,selling, purchasing varyingetc.	Numberof securities towhich theoption relates (Note 7)	Exercise price	Type,e.g. American, Europeanetc.	Expiry date	Optionmoney paid/received perunit (Note 5)
N/A

(ii) Exercising

Productname, e.g.calloption	Numberofsecurities	Exercisepriceper unit (Note 5)
N/A

(d) Otherdealings(includingtransactionsinrespectofnewsecurities)(Note4)

Natureoftransaction (Note 8)	Details	Priceperunit (ifapplicable) (Note 5)
N/A

4. OTHERINFORMATION
Agreements,arrangementsorunderstandingsrelatingtooptionsorderivatives

Fulldetails of any agreement, arrangement or understanding betweenthepersondisclosing andanyotherpersonrelatingtothevotingrightsofanyrelevantsecuritiesunderanyoption referredtoonthisform or relating to the voting rights or future acquisition or disposal ofany relevantsecuritiestowhichanyderivativereferredtoonthisformisreferenced.Ifnone,this shouldbestated.

N/A

IsaSupplementalForm8attached? (Note 9)
NO
Date of disclosure
25^th November 2025

Contactname
Divya K

        
Telephonenumber                                

+918067452364
IfaconnectedEFM,nameofofferee/offeror withwhichconnected
N/A
IfaconnectedEFM,statenatureof connection (Note 10)
N/A